首页|Data on Artificial Intelligence Reported by Guilherme Jose Aguilar and Colleague s (Development and Content Analysis Protocol for Evaluating Artificial Intellige nce in Drug-Related Information)
Data on Artificial Intelligence Reported by Guilherme Jose Aguilar and Colleague s (Development and Content Analysis Protocol for Evaluating Artificial Intellige nce in Drug-Related Information)
扫码查看
点击上方二维码区域,可以放大扫码查看
原文链接
NETL
NSTL
By a News Reporter-Staff News Editor at Robotics & Machine Learning DailyNews Daily News - New research on Artificial Intelligenc e is the subject of a report. According tonews reporting originating from Sao P aulo, Brazil, by NewsRx correspondents, research stated, “Artificialintelligenc e (AI) has significant transformative potential across various sectors, particul arly in healthcare. This study aims to develop a protocol for the content analy sis of a method designed to assess AIapplications in drug-related information, specifically focusing on contraindications, adverse reactions, anddrug interact ions.”